1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 18th March 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging (2018) Chen et al

Discussion in 'Other health news and research' started by Webdog, Jul 26, 2018.

  1. Webdog

    Webdog Senior Member (Voting Rights)

    Messages:
    2,265
    Location:
    Holodeck #2
    Abstract:
    Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging
    https://jamanetwork.com/journals/jamaneurology/article-abstract/2687472

    Press release:
    Yale-developed test for Alzheimer’s disease directly measures synaptic loss
    https://news.yale.edu/2018/07/16/ya...imers-disease-directly-measures-synaptic-loss
     
    Melanie likes this.

Share This Page